NGNE
USDNeurogene Inc. Common Stock
$26.750+0.625 (2.392%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$26.125
High
$26.970
Low
$23.930
Volume
0.16M
Company Fundamentals
Market Cap
381.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.20M
Exchange
NGM
Currency
USD
52-Week Range
Low $6.875Current $26.750High $74.49
Related News
Analyst Upgrades
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
View more
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $65
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Neurogene with a Buy and raises the price target from $45 to $65.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.